The Union Public Service Commission (UPSC) has decided to share online scores of candidates taking competitive exams in order to boost hiring by the private sector. As per the government’s proposal, the scores of the candidates taking part in the competitive exams will be linked to the Integrated Information System for Public Recruitment Agencies, which will be a dedicated website being developed by the National Informatics Centre (NIC). The scores made available in the website will act as a useful database for other employers to identify good, employable candidates. Under the proposal, the UPSC has decided to disclose information such as name, date of birth, category (whether SC, ST or physically handicapped) educational qualifications, total marks obtained in the written examination and interview, address, e-mail id and mobile numbers of those candidates who have reached the final stage of examination (interview) but were “not recommended” by the commission. As per the proposal, the candidates can either opt in or out of the disclosure scheme by making an appropriate response in the application form. The UPSC will dispense information about the disclosure scheme in its notice to various exams covered by this scheme. However, candidates appearing for the recruitment exams for the armed forces and those applying for limited departmental competitive examinations and the Central Industrial Security Force will not be covered under the disclosure scheme.
In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo...
Comments
Post a Comment